Stay informed and entertained with our collection of news videos, bringing you the latest updates and information. Watch now to stay up-to-date!
Inflation and labor market data were in focus in the U.S. this week that was relatively less heavy for economics news flow. Preliminary estimates for the second quarter GDP gained attention in Europe. The central bank decision from Australia and a rating upgrade for India amid the tariff threats, made headlines in Asia.
Central bank decisions, foreign trade data and industrial orders figures were among the highlights this week that saw relations between the U.S. and India hit a new low after President Donald Trump announced a 50 percent tariff on exports from the latter in retaliation for buying Russian oil. That is among the highest slapped on countries exporting to the U.S. In other main news, the Bank of England rate decision this week drew attention as policymakers went for a rare second vote.
Housing market data and jobless claims figures were the highlights this week in the U.S. In Europe, the European Central Bank was in focus as the policy decision announcement was due. Further, survey data threw light on the trends in the manufacturing and services sectors in the euro area. The Chinese central bank was in news in the Asia for the latest interest rate decision.
April 16, 2026 07:13 ETEli Lilly and Company (LLY) announced positive topline results from the Phase 3 ACHIEVE-4 trial evaluating the efficacy and safety of Foundayo or orforglipron, compared to insulin glargine in adults with type 2 diabetes and obesity or overweight at increased cardiovascular risk. In the trial, Foundayo...
April 10, 2026 01:04 ETTelix Pharmaceuticals Ltd. (TLX, TLX.AX) announced that the U.S. Food and Drug Administration has accepted its resubmitted New Drug Application or NDA for TLX101-Px (Pixclara, Floretyrosine F18 or 18F-FET), an investigational PET agent for the imaging of glioma (brain cancer). Telix Pharma shares...
May 04, 2026 09:29 ETa2 Milk Company Ltd. (ACOPF, A2M.AX), a dairy company, announced a recall of select infant milk formula, manufactured by Synlait Milk Limited and sold only in the United States, citing the presence of cereulide. The recall involves three batches of a2 Platinum USA label infant milk formula, comprising...